Revolutionizing wound care: Spectral MD's breakthrough imaging technology | News Direct

Revolutionizing wound care: Spectral MD's breakthrough imaging technology

News release by Spectral MD Holdings Ltd

facebook icon linkedin icon twitter icon pinterest icon email icon Vancouver | July 24, 2023 12:58 PM Eastern Daylight Time


Spectral MD Holdings general council Vince Capone joined Steve Darling from Proactive to share news about the company's deep view wound imaging technology.

Spectral MD is a Dallas-based company that has been developing digital wound assessment tools for analyzing and diagnosing wound healing. Their proprietary AI platform utilizes multispectral imaging, with billions of clinically validated data points, to provide rapid and accurate wound size measurement and documentation. Currently, their focus is on burn indications for acute care and diabetic foot ulcers for chronic wound care.

Capone explained that their technology uses breakthrough multispectral imaging, covering a range of lights from UV to visible to near-infrared, allowing for comprehensive wound assessment and documentation. The technology not only enables diagnostic tests but also helps determine if a wound is ready for advanced wound care treatment.

He also discussed Spectral MD's recent merger with Rosecliff, which will facilitate their migration from the AIM market to the NASDAQ, opening up opportunities for capital and expansion. Overall, Spectral MD's innovative wound imaging technology and its potential for growth in the wound care industry were highlighted, with the NASDAQ listing seen as a significant step toward further success.


Contact Details


Proactive Investors


+1 347-449-0879